Clinical Trials

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05448781 2022-07-07

Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

46 enrolled

Squamous Non-small Cell Lung Cancer

NCT04942301 2021-06-30

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Phase 1 Unknown

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04613284 2020-11-03

RELIEF

97 enrolled

Lung Neoplasms

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03008109 2017-01-04

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

Phase 3 Unknown

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

100 enrolled

Adenocarcinoma of Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

10 enrolled

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

60 enrolled

Lung Neoplasms

NCT02005120 2013-12-20

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01347424 2013-12-09

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

40 enrolled

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Nasopharyngeal Neoplasms

NCT01218594 2012-10-17

DP-EN-RT

50 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT01211002 2010-09-29

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

170 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01192230 2010-09-16

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01028729 2009-12-09

NSCLC

120 enrolled